A Gain-of-Function Mutation of <i>JAK2</i> in Myeloproliferative Disorders

20053,438 citationsJournal Articlebronze Open Access

Authors

A high proportion of patients with myeloproliferative disorders carry a dominant gain-of-function mutation of JAK2.

Good health and well-being

Published in: New England Journal of Medicine

Volume 352, Issue 17, pp. 1779-1790

Field-Weighted Citation Impact: 105.73